Lightcalls.com
 

O'CONNELL Tyne Pulling princes; the...

O'CONNELL Tyne Pulling princes; the Calypso chronicles. Bloomsbury 224p c2004 1-58234-957-6 $1695 JS

This is a first YA novel by way of an experienced British author best known for adult comedy novels. O'Connell one time attended a Catholic boarding drill in England, as do her concede three children, and so she is comfortable describing the life Calypso leads at just of the like kind a school. Calypso is actually an American, sent to St Augustine's from her California parents; as the story begins she still be impresseds like a misfit, even after several years at the place. Now 14 years elderly she has a new roommate and her life changes. She and her single true friend. Star (daughter of a strength star), are sharing a apartment with The Honorable Georgina Castle Orpington, and she and Star finally are learning what it is like to unite with the British aristocracy, for better and for worse. Calypso also propers Freddie, a royal prince, in a fencing instruction with the nearby boys' sect They strike up a flirtation that escalates into an incident that memorizes into all the British tabloids.

yet this doesn't give you any idea of just by what mode outrageously funny this story is: O'Connell writes just about everything for laughs. She satirizes the rich girls and their obsessions. She is kind toward the nun who hasten the school, who truly are intelligent, tolerant, and loving in their dealings with their wacky learners The girls hide vodka in their material part Shop bottles, they smoke and then spray Febreze around to shield the smell, they swear and intrigue against one another; they use their intelligence and creativity in madcap ways, and they actually do know to what extent to be loyal friends. This work (could it be first of a series?) fits right in with other sportive British teenage stories, but I think it has carved without its own niche in a posh boarding educate setting. Claire Rosser, KLIATT



COPYRIGHT 2004 Kliatt

COPYRIGHT 2004 Gale Group



Other Articles
 -Morphotek will collaborat...
 -Eksigent Technologies nam...
 -The benefits of outsourci...
 -Sartorius Corporation ...
 -In our previous column, w...
 -Efoora appointed Michael ...
 -Affymax appointed Anne-Ma...
 -Traditionally, continuous...
 -New Brunswick Scientific ...
 -The German-American firm ...
 -Don G. Burstyn, formerly ...
 -American patients are mor...
 -Summary Prior to va...
 -BioPharm Editorial Adviso...
 -Australia agreed to spend...
 -The Biotechnology Industr...
 -Ambion, The RNA Company i...
 -Therapies based on living...
 -A recent survey found tha...
 -ViroLogic will acquire Ac...
 -Cardinal Health named Joh...
 -One of the greatest chall...
 -As the president of a sma...
 -Sweden-based Biovitrum wi...
 -Nanogen appointed David L...
 -The Experion Process Know...
 -Although biomedical resea...
 -The Supreme Court of Cana...
 -Netherlands-based DSM Bio...
 -David A. Smoller joined S...
 -A few months ago, I wrote...
 -Panacos Pharmaceuticals w...
 -Karen K. Vaccaro will res...
 -Acceleron Pharma appointe...
 -Two quarterly meetings of...
 -Illinois-based Abbot Labo...
 -FKI Logistics announced t...
 -The following corrections...
 -It its widest definition,...
 -UK-based Xcellsyz will li...
 -Andrew P. Aromando joined...
 -Invitrogen's comprehensiv...
 -Last month, we described ...
 -The Swiss life sciences c...
 -Protein Design Labs (PDL)...
 -Model It HNMR, the newest...
 -Tech transfer, like chang...
 -QLT and Atrix Laboratorie...
 -Dendreon announced Christ...
 -Baxter Pharmaceutical Sol...
 -The biopharmaceutical ind...
 -GlaxoSmithKline announced...
 -Montreal-based Caprion Ph...
 -Xenova Group recently ann...
 -Cole-Parmer's new 192-pag...
 -Over the last decade ther...
 -Benchmark your facility p...
 -As biotechnology organiza...
 -Frederick D. Sancillo, fo...
 -Insmed acquired a recombi...
 -Baxter Pharmaceutical Sol...
 -Model It HNMR, the newest...
 -DA's regulation 21 CFR Pa...
 -Robert P. Ryan joined Ath...
 -A new report from Busines...
 -Biotest offers a complete...
 -Swagelok offers a brochur...
 -Partnering is a global ph...
 -Human Genome Sciences CEO...
 -Shorten the process devel...
 -The licensure of biotechn...
 -Rodger Currie joined Amge...
 -The GEA Filtration Model ...
 -A multi-channel chemistry...
 -From June 6-9, San Franci...
 -Skanska USA Building Inc....
 -New Brunswick Scientific'...
 -AVI BioPharma appointed P...
 -Ambion, The RNA Company, ...
 -"If you want to be a...
 -Xcellerex appointed Susan...
 -Researchers identified th...
 -Cool Spring Business Park...
 -In October 2003, Shenzhen...
 -Laureate Pharma appointed...
 -After a 6-5 vote by Calif...
 -QSourcing, a service of Q...
 -The recent discovery of &...
 -Affymax added Douglas L. ...
 -USDA recently approved tw...
 -BioPharm International is...
 -Serologicals has released...
 -This document by Shenzhen...
 -Robert Bronstein joined A...
 -Gloucester Gains Fujisawa...
 -With more than 30 years o...
 -Pall's SUPRAdisc II depth...
 -In today's competitive ma...
 -Protein Design Labs repor...
 -Charles A. Rice will repl...
 -AstraZeneca's Faslodex (f...
.
© 2006 Lightcalls.com All rights reserved.